The European Commission (EC) is increasingly invoking conglomerate theories of harm in its merger reviews. The complexity of these theories is resulting in more in-depth Phase 2 reviews and behavioral access commitments are relatively common for conglomerate mergers in the high-tech space.

Read this chapter in Shearman & Sterling's 2019 Antitrust Annual Report, "Conglomerate Effects: An EU Resurgence?"

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.